XT
RVPH

XTX Topco’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

XTX Topco’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,215
Closed -$45.8K – 4306
2025
Q4 		$45.8K Buy
8,215
+3,195
+64% +$35.5K ﹤0.01% 2859
2025
Q3 		$37K Buy
5,020
+922
+22% +$7.84K ﹤0.01% 2224
2025
Q2 		$31.2K Buy
+4,098
New +$63.8K ﹤0.01% 2100
2025
Q1 		– Sell
-1,251
Closed -$45.3K – 3002
2024
Q4 		$45.3K Buy
+1,251
New +$34.8K ﹤0.01% 1914
2023
Q1 		– Sell
-2,924
Closed -$249K – 1617
2022
Q4 		$249K Buy
+2,924
New +$223K 0.05% 707

Other funds holding RVPH

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

XTX Topco's RVPH Position: Q1 2026 in Review

XTX Topco sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q1 2026, closing a stake of 8,215 shares — an estimated $45.8K sold.

XTX Topco first reported a position in RVPH in Q4 2022 and held it in 5 quarters. The position peaked at $249K in Q4 2022. 35 funds tracked by Wall St. Rank hold RVPH as of Q1 2026.

  • XTX Topco reported no remaining REVIVA PHARMA HLDGS INC position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 8,215 REVIVA PHARMA HLDGS INC shares in Q1 2026, an estimated $45.8K.
  • XTX Topco first reported a position in REVIVA PHARMA HLDGS INC in Q4 2022 and held it in 5 quarters.
  • XTX Topco's REVIVA PHARMA HLDGS INC position peaked at $249K in Q4 2022.
  • 35 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.